The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 27,201–27,300 of 31,469
van den Berg, E. (2004) · Utrecht University Repository (Utrecht University) · Cited by 2
Cholesterol metabolism in type 2 diabetes
Simonen, P. P. (2002) · Työväentutkimus Vuosikirja · Cited by 2
Adiponectin Gene Polymorphism and Carotid Artery Intima-Media thickness in Type 2 Diabetes
Kang, E. S., Park, S., Kim, S. H., Lee, H. J., Hur, K. Y., Han, S. J., Park, S. E., Kim, H. J., Ahn, C. W., Soo, B., et al. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.1.29 · Cited by 2
Morales, M. Z., Salgado, E. F., Balzán, L., et al. (2014) · PubMed · Cited by 2
Ajibola, A. (2014) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 2
Cardiovascular risk factors in patients with severe mental illness
Birkenaes, A. B. (2008) · NORA - Norwegian Open Research Archives · Cited by 2
Management of Endocrine Failure in Chronic Pancreatitis
Andersen, D. K. (2016) · doi:10.3998/panc.2016.6 · Cited by 2
Barreto, F. K. D. A. (2016) · Cited by 2
Brar, I. (2014) · UWSpace (University of Waterloo) · Cited by 2
A systems engineering approach to coronary heart disease
Mathews, M. J. (2015) · Cited by 2
Leptin : a risk marker for cardiovascular disease
Söderberg, S. (1999) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2
Lan‐Pidhainy, X. (2012) · TSpace (University of Toronto) · Cited by 2
Fedko, I. O., Nivard, M. G., Hottenga, J., Zudina, L., CHARGE Inflammation working group Cross Consortia Pleiotropy (XC-Pleiotropy) Group, Balkhiyarova, Z., Chasman, D. I., Ganesh, S. K., Huang, J., Nalls, M. A., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/496802 · Cited by 1
Fingerprinting Adiposity and Metabolic Function in the Brains of Overweight and Obese HumansPreprint
Farruggia, M. C., van Kooten, M. J., Burke, M. V., Scheinost, D., Constable, R. T., & Small, D. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/540997 · Cited by 2
Data on metabolic profile of insulin-degrading enzyme knockout mice
Borges, D. O., Meneses, M. J., Dias, T. R., et al. (2019) · Data in Brief · doi:10.1016/j.dib.2019.104023 · Cited by 2
Grangeiro, É. D., Trigueiro, M. S., Siais, L. D. O., Paiva, H. M., Sola‐Penna, M., & Rosado, E. L. (2020) · Preprints.org · doi:10.20944/preprints202005.0436.v1 · Cited by 2
A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
Elsayed, A. (2020) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 2
Contribution of de novo lipogenesis to the progression of nonalcoholic fatty liver disease
Abdul, M. M. S. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/81575 · Cited by 2
Batista-da-Silva, B. (2020) · doi:10.14393/ufu.di.2020.641 · Cited by 2
Tuomisto, K., Palmu, J., Long, T., et al. (2021) · medRxiv · doi:10.1101/2021.07.23.21260986 · Cited by 2
Fukui, T. (2007) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock2005.21.57 · Cited by 2
Michalichen, K. C., Weber, V. M. R., Queiróga, M. R., Fernandes, D. Z., Carreira, C. M., Vieira, E. R., & Venturini, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1338456/v1 · Cited by 2
Marañón, P., Fernández-García, C. E., Isaza, S. C., et al. (2022) · medRxiv · doi:10.1101/2022.03.17.22272494 · Cited by 2
Li, P., Ji, B., Lappa, D., Meijnikman, A. S., Olsson, L. M., Aydin, Ö., Bruin, S. C., van de Laar, A. W. J. M., Tremaroli, V., Luo, H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.26.489057 · Cited by 3
Oda, K., & 小田, 和. (n.d.) · Institutional Repositories DataBase (IRDB) · Cited by 2
S-9-PAHSA regulates glycolipid metabolism by enhancing autophagy and upregulating PI3K/AKT pathwayPreprint
Yu, Z.-Y., Lin, J., Wang, J., Liu, Y., Zhang, X.-M., Wen, X.-H., Zhang, Q., Xu, X.-D., He, C.-F., Xue, W.-J., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1618637/v1 · Cited by 2
Silva, J. P. D., Wargny, M., Raffin, J., Croyal, M., Duparc, T., Combes, G., Genoux, A., Perret, B., Vellas, B. J., Guyonnet, S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1819108/v2 · Cited by 2
Raets, L., Minschart, C., Van, D. B. A., Van, E. B. E., Van, C. P., Moyson, C., Verhaeghe, J., Vandeginste, S., Verlaenen, H., Vercammen, C., et al. (2022) · Endocrine Abstracts · doi:10.1530/endoabs.84.ps3-13-115 · Cited by 2
Brain glucose metabolism and ageing: A 5-year longitudinal study in a large PET cohortPreprint
Pak, K., Malén, T., Santavirta, S., Shin, S., Nam, H.-Y., Mæyer, S. D., & Nummenmaa, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.15.508088 · Cited by 2
GABAergic LRP1 is a key link between obesity and memory functionPreprint
Üner, A. G., Hou, Z.-S., Aydogan, A., RODRIGUES, K., Young, J., Choi, A., Yang, W., Kim, W. S., Prévot, V., Caldarone, B. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.17.508390 · Cited by 2
Ekberg, N. R., Hellberg, A., Sundqvist, M. L., Hirschberg, A. L., Catrina, S., & Brismar, K. (2023) · Research Square · doi:10.21203/rs.3.rs-2405214/v1 · Cited by 3
Zhou, Z., Lu, Y., Li, J., An, Y., Jiang, W., & Wang, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-2505907/v1 · Cited by 1
Liu, S.-X., Bai, H., Guan, L., Liu, X., Fan, P., Zhou, M., Wu, Y., Tang, F., Wang, Y., & Li, D. (2023) · PubMed Central · doi:10.12182/20230160512 · Cited by 2
Analysis of Link between Brain Insulin Resistance and Alzheimer's Disease: A Systematic ReviewPreprint
Andrade, L. J. D. O., de Oliveira, L. M., Bittencourt, A. M. V., Lourenço, L. G. D. C., & de Oliveira, G. C. M. (2023) · Research Square · doi:10.21203/rs.3.rs-2852332/v1 · Cited by 2
Ojha, A., & Watve, M. (2024) · Qeios · doi:10.32388/gl52db · Cited by 4
Silva, L. F. R., Garcia, B. C. C., Esteves, E. A., Mang, Z. A., Amorim, F. T., Dias‐Peixoto, M. F., Gripp, F., Tricoli, V., & Magalhães, F. D. C. (2024) · Research Square · doi:10.21203/rs.3.rs-3744670/v1 · Cited by 2
Gora, A., Tiwari, P., Saxena, A., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4340896/v1 · Cited by 2
Cefis, M., Marcangeli, V., Hammad, R., Granet, J., Leduc‐Gaudet, J., Gaudreau, P., Trumpff, C., Huang, H., Picard, M. A., Aubertin‐Leheudre, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.09.602758 · Cited by 2
Kahal, H. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Lin, C.-W. (2011) · doi:10.17077/etd.9huqp2h8 · Cited by 2
Patterson, M. A. (2014) · Cited by 2
Avaliação da resistência insulínica e do perfil lipídico na síndrome de turner
Armani, M. C. D. A., Baldin, A. D., de Lemos‐Marini, S. H. V., Baptista, M. T. M., Maciel‐Guerra, A. T., & Guerra‐Júnior, G. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000200015 · Cited by 1
Murphy, M., Nicaud, V., Martin, B., et al. (2005) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563054890060 · Cited by 1
Malara, M., & Lutosławska, G. (2011) · Biomedical Human Kinetics · doi:10.2478/v10101-011-0006-5 · Cited by 1
Jeong, D. W., Lee, J. G., Lee, S. Y., Kim, Y. J., Bae, J. H., Kim, D., Yi, Y. H., Cho, Y. H., & Chae, U. (2012) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-012-0069-z · Cited by 1
Iwahashi, H., Fukuda-Akita, E., Fukuda-Tokunaga, A., Okita, K., Horikawa, Y., Imagawa, A., Funahashi, T., Shimomura, I., & Yamagata, K. (2011) · Diabetology International · doi:10.1007/s13340-011-0046-7 · Cited by 1
Can, A. S., Özbayrakçı, S., Palaoğlu, K. E., & Bersot, T. P. (2009) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00032.x · Cited by 1
Effect of stabilized rice bran-added high sucrose diet on glucose control in C57BL/6 mice
Lee, S.-M., Shin, M.-S., & Heo, Y.-R. (2014) · Journal of Nutrition and Health · doi:10.4163/jnh.2014.47.3.157 · Cited by 1
Mackawy, A. M. H., & Ahmed, E. A. A. (2015) · Journal of Clinical & Medical Genomics · doi:10.4172/2472-128x.1000135 · Cited by 1
Caffeine intake and the plasma proteome
Tian, O., Josse, A. R., & El‐Sohemy, A. (2013) · The FASEB Journal · doi:10.1096/fasebj.27.1_supplement.1080.3 · Cited by 1
Haapala, E. A., Paananen, J., Hiltunen, M. O., & Lakka, T. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180216 · Cited by 1
The role of osteocalcin in mechanism of Steroid induced diabetes mellitus
Holla, A., Sudha, V., Laxminarayan, B., Nandakrishna, B., Shastry, B. A., Asha, K., Hande, M., & Shalini, A. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00791-6 · Cited by 1
Abdel-Hamed, A. R., Abo–Elmatty, D. M., & El-Darder, O. M. (2020) · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences · doi:10.21608/rpbs.2020.32285.1066 · Cited by 1
PREDİYABET HASTALARINDA D VİTAMİNİ VE PARATHORMONA GÖRE İNSÜLİN DİRENCİNİN DEĞERLENDİRİLMESİ
Erdoğdu, H. İ. (2020) · Sakarya Medical Journal · doi:10.31832/smj.683489 · Cited by 1
Rojas, L. Z., Gamboa-Delgado, E. M., & Quintero-Lesmes, D. C. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0362 · Cited by 1
Índice de evaluación del modelo de homeostasis (HOMA) y resistencia a la insulina en la psoriasis
Romero‐Pérez, D., Belinchón, I., & Rincón, J. M. R. (2020) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2020.01.008 · Cited by 1
Pawar, R. S., Lakshmi, P. K., Kumar, S., Dobriyal, N., & Sahi, C. (2020) · Pharmacognosy Magazine · doi:10.4103/pm.pm_366_20 · Cited by 1
Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models
Wu, C., Chang, L.-C., Cheng, C., Fang, T., Lin, Y., Pei, D., & Chen, J.-S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073407 · Cited by 2
Aludwan, M., Kobyliak, N. M., Павленко, Г. П., et al. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.16.8.2020.222881 · Cited by 1
Olaniyi, K. S., Sabinari, I. W., & Olatunji, L. A. (2021) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2021.100099 · Cited by 1
Sinorita, H., Purnomo, L. B., & Pramono, R. B. (2021) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci005302202102 · Cited by 1
Гриценко, О. В., Chumakova, G. A., & Trubina, E. V. (2021) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2021-27-3-269-278 · Cited by 1
Factores sociodemográficos y de riesgo cardiovascular asociados a obesidad severa en niñas
Ramírez, J. P., Henostroza, O. C., & Ramírez, A. A. (2021) · Anales de la Facultad de Medicina · doi:10.15381/anales.v82i1.20497 · Cited by 1
Alptekin, Ö., Tükel, S. S., Turan, B., et al. (2021) · Journal of the Turkish Chemical Society Section A Chemistry · doi:10.18596/jotcsa.945582 · Cited by 1
Lowering of Blood Glucose Levels with the Peptide Mixture Deglusterol in In Vitro and In Vivo Models
Kim, E. M., Kim, S. S., & Chung, Y. J. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2021.k.0159 · Cited by 1
Dobhal, S., Baliyan, S., Singh, M., et al. (2021) · European Pharmaceutical Journal · doi:10.2478/afpuc-2021-0015 · Cited by 1
Abdou, M., Hassan, M. M., ELatty, S. A., Aiad, D. N., & Ibrahim, A. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.8877 · Cited by 1
Sedky, A. A. (2022) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2022.234979 · Cited by 1
Sreenivasulu, G., Vishwanathan, K., Prasad, K. A. R., et al. (2022) · Journal of Dental Panacea · doi:10.18231/j.jdp.2022.017 · Cited by 1
Kumar, V., Bolanthakodi, N., Vidyasagar, S., Holla, A., Sheik, S. M., & Abhishek, S. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01087-y · Cited by 1
Khodarahmi, M., Khah, A. S., Farhangi, M. A., et al. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00328-3 · Cited by 1
ERÇAKIR, M., & Bayram, S. (2022) · Gazi Sağlık Bilimleri Dergisi · doi:10.52881/gsbdergi.1052740 · Cited by 1
Effect of Laparoscopic Sleeve Gastrectomy on Serum Levels of Resistin, Visfatin, and Apelin
Çalışkan, P., Çağlar, T. R., Seyit, H., Çağlar, H. G., Vural, M., & Kural, A. (2022) · Bariatric Surgical Practice and Patient Care · doi:10.1089/bari.2021.0130 · Cited by 1
Diwan, A. G., Vora, A., Vaidya, N., Padwal, M. K., & Momin, A. A. (2022) · Bharati Vidyapeeth Medical Journal · doi:10.56136/bvmj/2022_00031 · Cited by 1
Zhang, X., Guérin, S., Launay, Y., Serrand, Y., Coquery, N., & Val‐Laillet, D. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4384693 · Cited by 1
The association between carbon and nitrogen stable isotope ratios of human hair and hypertension
Ahn, S. V., & Park, J.-K. (2023) · Clinical Hypertension · doi:10.1186/s40885-022-00228-z · Cited by 1
Welsch, S., Mailleux, V., de Beaulieu, P. L. H., Ranguelov, N., Godefroid, N., Robert, A. R., Stéphenne, X., Scheers, I., Reding, R., Sokal, E. M., et al. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1080905 · Cited by 1
Cha, B.-K. (2023) · Journal of Korean Academy of Fundamentals of Nursing · doi:10.7739/jkafn.2023.30.1.66 · Cited by 1
Rosa, F. T., Fatel, E. C. D. S., Alfieri, D. F., Flauzino, T., Scavuzzi, B. M., Lozovoy, M. A. B., Iriyoda, T. M. V., Simão, A. N. C., & Dichi, I. (2023) · PharmaNutrition · doi:10.1016/j.phanu.2023.100341 · Cited by 1
Miki, T., Chen, S., Eguchi, M., Kochi, T., Fukunaga, A., Nanri, A., Kabe, I., & Mizoue, T. (2023) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2023.04.004 · Cited by 1
Wu, H., Lin, X., Cheng, C., Jiang, H., Iqbal, J., Liu, J., & Zhou, H. (2023) · NMR in Biomedicine · doi:10.1002/nbm.4985 · Cited by 1
Soleimani, A., & Fathi, M. (2022) · مجله دانشگاه علوم پزشکی اراک · doi:10.32598/jams.25.2.4334.6 · Cited by 1
Assessment of Insulin Secretion and Insulin Resistance
Park, S. Y. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.2.66 · Cited by 1
Zhang, Z., Gao, Q. F., Li, S., et al. (2023) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2023.101166 · Cited by 1
Jabłonowska-Lietz, B., Nowicka, G., Włodarczyk, M., Rejowski, S., Stasiowska, M., & Wrzosek, M. (2023) · Biomedicines · doi:10.3390/biomedicines11082304 · Cited by 2
Bublitz, M. H., Anderson, M. R., Sanapo, L., Scarfo, V. N., & Bourjeily, G. R. (2023) · American Journal of Perinatology · doi:10.1055/s-0043-1772749 · Cited by 1
ASSESSMENT OF OXIDATIVE STRESS AND ANTIOXIDANT STATUS IN TYPE 1 DIABETES MELLITUS
Fathi, F. H., Mohammad, J. A., & Almulathanon, A. A. Y. (2023) · Military Medical Science Letters · doi:10.31482/mmsl.2023.015 · Cited by 1
Ramzan, F., Sequeira, I. R., Lu, L. W., Mitchell, C. J., D’Souza, R. F., Vickers, M. H., Poppitt, S. D., & Cameron‐Smith, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814393 · Cited by 1
Oliveira, J. G. D. S., Santos, B. D. C., Santos, R. K. F., Santos, C. B., Reis, A. R., Santos, C. F. D. S., de Carvalho, G. D., Brandão-Lima, P., Rocha, V. D. S., & Pires, L. V. (2023) · American Journal of Human Biology · doi:10.1002/ajhb.23999 · Cited by 2
Hu, T., Xu, Y., Shen, Y., et al. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117606 · Cited by 1
Muller, C. H. D. L., Schroeder, H. T., Farinha, J. B., et al. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00994-w · Cited by 1
Kocabaş, G. Ü., Şimşir, İ. Y., Yürekli, B. Ş., et al. (2023) · Obstetric Medicine · doi:10.1177/1753495x231216032 · Cited by 1
Colosimo, S., Martínez‐Sánchez, M. A., Román, A. B., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.12.008 · Cited by 1
Definition, Klassifikation, Diagnostik und Differenzialdiagnostik des Diabetes mellitus: Update 2023
Pleus, S., Tytko, A., Landgraf, R., Heinemann, L., Werner, C., Müller‐Wieland, D., Ziegler, A., Müller, U., Freckmann, G., Kleinwechter, H. J., et al. (2024) · Die Diabetologie · doi:10.1007/s11428-023-01127-z · Cited by 1
Wang, Z., van Faassen, M. H. J. R., Groen, H., Cantineau, A. E., van Oers, A. M., van der Veen, A., Hawley, J. M., Keevil, B. G., Kema, I. P., & Hoek, A. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.01.007 · Cited by 1
Aguree, S., Owora, A. H., Hawkins, M. A. W., & Gletsu-Miller, N. A. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589241240059 · Cited by 1
Li, X., Lin, J., Hu, C., Liu, B., Li, F., Li, J., Zeng, X., Li, S., Mi, Y., Yin, X., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-075873 · Cited by 2
Urakami, T., Terada, H., Mine, Y., et al. (2024) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2024-0009 · Cited by 1
Aboudeya, H. M., Abdou, A. S., Attia, M. M., Shaker, S. A., & Younis, S. A. (2024) · Sport Sciences for Health · doi:10.1007/s11332-024-01206-8 · Cited by 1
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
